B7-H3 Chimeric Antigen Receptor T Cells (B7-H3CART) in Recurrent Glioblastoma Multiforme

Clinical trial NCT05474378 · RECRUITING

Trial details

NCT number: NCT05474378
Sponsor: Stanford University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Nervous System

Start date: 2022-07-12
Primary completion: 2026-08-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.